SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense trading activity as market participants speculate on a potential acquisition by major tech players like Amazon, following reports of ongoing buyout talks that have triggered a massive surge in volume. The community is actively debating the implications of this possible deal, contrasting the potential buyout premium against current market valuations while weighing the company's critical role in satellite connectivity and its long-standing partnership with Apple.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is in the spotlight as investors anticipate the upcoming Artemis II mission, which marks the first crewed deep-space flight in over 50 years. The community is actively debating the stock's long-term potential within the lunar economy while closely monitoring technical price levels and market-wide volatility driven by geopolitical tensions.

Launchr is a programmable creator fee engine designed to adapt to every stage of a token’s lifecycle.  Instead of hard coded splits or one time choices, Launchr lets creators dynamically route fees in real time based on market conditions, liquidity depth, and strategy.

Launchr

Investors are actively debating the viability and longevity of the token amidst high-energy launch promotion and community efforts to drive trading volume. While some participants focus on the excitement of early-stage momentum, others are voicing caution regarding the sustainability of these types of market movements.

nCino, Inc. engages in the provision of cloud-based software applications for financial institutions in the United States and internationally. Its nCino Bank Operating System, a tenant cloud platform, digitizes, automates, and streamlines complex processes and workflow, and utilizes data analytics and artificial intelligence and machine learning (AI/ML) to enable financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposit and other accounts, and manage regulatory compliance. The firm's nCino IQ is an application suite that utilizes data analytics and AI/ML to provide its customers with automation and insights into their operations, such as tools for analyzing, measuring, and managing credit risk, as well as to enhance their ability to comply with regulatory requirements. The company was founded by Pierre Naudé in 2011 and is headquartered in Wilmington, NC.

Ncino Inc.

nCino is currently in focus following a significant expansion of its stock repurchase program, which has fueled positive community sentiment regarding the company's long-term capital allocation strategy. Investors and analysts are actively debating the stock's valuation after strong earnings performance and management's focus on accelerating growth in its cloud banking and AI-driven product offerings.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz Global Holdings Inc

Hertz is currently at the center of a tug-of-war between retail traders anticipating a turnaroundfueled by speculation of increased institutional involvement, potential short squeeze setups, and seasonal travel tailwindsand skeptics highlighting significant debt and earnings volatility. The community remains heavily focused on monitoring call flow and technical indicators, with intense debate over whether current price levels offer a deep-value opportunity or if the stock remains trapped by structural headwinds.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing heightened volatility as retail traders speculate on a potential short squeeze, frequently comparing its low float and share structure to past parabolic meme stock runs. While some community members anticipate a massive rally based on historical spikes, others warn of significant downside risk, characterizing the activity as a high-stakes pump and dump involving extreme borrowing fees.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is gaining attention as investors digest new contract awards and the company's expanding role in national security and NASA lunar missions. The community is actively debating the impact of ongoing insider selling by private equity firms against the stock's long-term potential in the growing space and defense sectors.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is capturing significant investor interest as the community reacts to a confirmed launch window for the BlueBird-7 satellite, serving as a critical catalyst after recent price volatility. Discussions are heavily focused on the stock's long-term infrastructure potential versus the risks of execution delays, with investors debating whether to treat recent pullbacks as prime accumulation opportunities ahead of broader sector growth.

iShares Trust - iShares U.S. Treasury Bond ETF

iShares U.S. Treasury Bond ETF

Investors are actively debating the role of GOVT and broader Treasury ETFs amid concerns over rising national debt, shifting Federal Reserve rate expectations, and increased foreign buying of U.S. government debt. Market participants are split between using these bonds as a defensive hedge against potential economic volatility and warning that current yield levels may not sufficiently compensate for long-term fiscal risks.

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals is trending as investors monitor the company's progress in expanding its obesity treatment pipeline, particularly following positive trial data and regulatory milestones for its core asset, IMCIVREE. The community remains focused on the potential for strategic M&A activity and the clinical success of upcoming candidates targeting hypothalamic obesity, which many see as a major value-driving catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Equities Analysts Offer Predictions for TSE:FRX Q1 Earnings

Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at HC Wainwright lowered their Q1 2026 earnings estimates for Fennec Pharmaceuticals in a report issued on Monday, March 30th. HC...

HC Wainwright Has Bearish Forecast for FENC Q1 Earnings

Adherex Technologies Inc. (NASDAQ:FENC - Free Report) - Analysts at HC Wainwright dropped their Q1 2026 earnings per share (EPS) estimates for shares of Adherex Technologies in a research note issued...

HC Wainwright Issues Negative Forecast for FENC Earnings

Adherex Technologies Inc. (NASDAQ:FENC - Free Report) - Research analysts at HC Wainwright cut their Q3 2026 EPS estimates for shares of Adherex Technologies in a note issued to investors on Monday, March 30th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings pe...

HC Wainwright Issues Negative Forecast for TSE:FRX Earnings

Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at HC Wainwright dropped their Q3 2026 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a report issued on Monday, March 30th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company...

Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below 50-Day Moving Average   - Should You Sell?

Fennec Pharmaceuticals (TSE:FRX) Shares Pass Below 50-Day Moving Average - Here's Why...

Adherex Technologies (FENC) to Release Earnings on Wednesday

Adherex Technologies (NASDAQ:FENC) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at...

Adherex Technologies Q4 Earnings Call Highlights

Fennec Pharmaceuticals reported record commercial growth for PEDMARK during its fourth quarter and full year 2025 earnings call, highlighting expanding adoption in both new and existing accounts...

Adherex Technologies (NASDAQ:FENC) Announces Earnings Results

Adherex Technologies (NASDAQ:FENC - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.18). The business had revenue of $13.78 million during the quarter, compared to analyst...

Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Adherex Technologies (FENC) delivered earnings and revenue surprises of -540.00% and -7.94%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Fennec Pharmaceuticals (FENC) to release Q4 earnings on March 24. Analysts expect EPS of $0.04 and revenue of $14.73 million. Stock gained 1.8% on Monday.read more...

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Fennec Pharmaceuticals Inc

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

FENC
Fennec Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FENC News

FENCFennec Pharmaceuticals Inc